John P. Butler, CEO and President: Akebia Therapeutics AKBA Buy · Filed 03/05

Trade details

Type: Insider buy
Amount: $86,587.5
Shares · price: 69,270 sh · $1.25 a share
Held after: 3,367,064 sh
Stock: Akebia Therapeutics AKBA
Person: John P. ButlerCEO and President
Trade date: 26/03/04
Filed: 26/03/05
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 1 insiders
Holding change: +2.1%

Akebia Therapeutics trades, last 26 weeks

What else happened in Akebia Therapeutics around then

Filed or reported within 30 days of the trade day · 02/02~04/03

John P. Butler's recent trades

John P. ButlerCEO and President
Sell10b5-1 planAkebia Therapeutics
Sell10b5-1 plan
Akebia Therapeutics
AKBA
$159.7K
114,891 sh
$159.7K
Filed 02/04
Traded 02/02
John P. ButlerCEO and President
Sell10b5-1 planAkebia Therapeutics
Sell10b5-1 plan
Akebia Therapeutics
AKBA
$133.5K
96,065 sh
$133.5K
Filed 02/04
Traded 02/02
John P. ButlerCEO and President
Sell10b5-1 planAkebia Therapeutics
Sell10b5-1 plan
Akebia Therapeutics
AKBA
$116.3K
83,689 sh
$116.3K
Filed 02/04
Traded 02/02
John P. ButlerCEO and President
Sell10b5-1 planAkebia Therapeutics
Sell10b5-1 plan
Akebia Therapeutics
AKBA
$64.9K
46,660 sh
$64.9K
Filed 02/04
Traded 02/02
John P. ButlerCEO and President
Planned sale10b5-1 planAkebia Therapeutics
Planned sale10b5-1 plan
Akebia Therapeutics
AKBA
$476K
341,305 sh
$476K
Filed 02/02
Traded 02/02